New US treatment guidelines recommend antiretroviral treatment for all people with HIV
Cognitive function improves through the first year of HIV therapy
Elvitegravir Quad pill matches efavirenz and atazanavir combos
Protease inhibitor not superior to NNRTI in sub-Saharan Africa
Cotrimoxazole prophylaxis is cost-effective for people starting ART in sub-Saharan Africa
New BHIVA guidelines recommend discussion with all patients on potential of HIV treatment to protect sexual partners
